Assignee
RAPTOR PHARMACEUTICALS INC
US·8 granted patents·10 pending applications·75 citations·filing 2006–2016
Top patents by PatentIndex Score
18 records- 0195US7700554B2Compositions for modulating blood-brain barrier transportRAPTOR PHARMACEUTICALS INC·Filed 2006·Granted Apr 20, 2010·44 cites·2 claims
- 0290US9717738B2Aerosol fluoroquinolone formulations for improved pharmacokineticsRAPTOR PHARMACEUTICALS INC·Filed 2016·Granted Aug 1, 2017·6 cites·29 claims
- 0388US9326936B2Aerosol fluoroquinolone formulations for improved pharmacokineticsRAPTOR PHARMACEUTICALS INC·Filed 2014·Granted May 3, 2016·7 cites·17 claims
- 0486US9173851B1Delayed release cysteamine bead formulation, and methods of making and using sameRAPTOR PHARMACEUTICALS INC·Filed 2015·Granted Nov 3, 2015·7 cites·8 claims
- 0586US7829537B2Receptor associated protein (RAP) conjugatesRAPTOR PHARMACEUTICALS INC·Filed 2009·Granted Nov 9, 2010·6 cites·13 claims
- 0681US9233077B2Delayed release cysteamine bead formulation, and methods of making and using sameRAPTOR PHARMACEUTICALS INC·Filed 2014·Granted Jan 12, 2016·5 cites·23 claims
- 0761US2016279138A1Aerosolized fluoroquinolones and uses thereofRAPTOR PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0859US9326971B24-methylpyrazole formulations for inhibiting ethanol intoleranceRAPTOR PHARMACEUTICALS INC·Filed 2014·Granted May 3, 2016·0 cites·15 claims
- 0958US9435785B2Methods for analyzing cysteamine compositionsRAPTOR PHARMACEUTICALS INC·Filed 2014·Granted Sep 6, 2016·0 cites·18 claims
- 1057US2016331704A1Delayed Release Cysteamine Bead Formulation, and Methods of Making and Using SameRAPTOR PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1155US2016158170A1Delayed Release Cysteamine Bead Formulation, And Methods Of Making And Using SameRAPTOR PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1255US2016341706A1Methods for Analyzing Cysteamine CompositionsRAPTOR PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1355US2016095827A1Delayed release cysteamine bead formulation, and methods of making and using sameRAPTOR PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1451US2017007578A1Genotype Specific Methods for Treating Human Subjects Using 4-MethylpyrazoleRAPTOR PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1550US2016243082A14-Methylpyrazole Formulations for Inhibiting Ethanol IntoleranceRAPTOR PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1644US2015125526A1Use of Cysteamine and Derivatives Thereof to Treat Mitochondrial DiseasesRAPTOR PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1737US2016128954A1Methods of Treating Huntington's Disease Using Cysteamine CompositionsRAPTOR PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1831US2016151332A14-Methylpyrazole FormulationsRAPTOR PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when RAPTOR PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →